Author

S. Martinelli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:spatial domain detection· 1 Assay:spatial transcriptomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. Bocedi· 1 shared A. Lauri· 1 shared A. Quercioli· 1 shared B. Biondi· 1 shared C. De Faveri· 1 shared C. Nixon· 1 shared C. Peggion· 1 shared C. R. Wilson· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

A. Bocedi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spatial resolution of transcriptomic plasticity states underpinning lethal morphologies in lung adenocarcinoma

H. L. Williams, N. Poulain, I. Powley, S. Martinelli, R. Bielik, H. Leslie, C. Nixon, C. R. Wilson, M. Sereno, Z. He, L. Officer-Jones, F. Ballantyne, R. Pennie, C. S. Wood, D. Y. Lewis, , J. Le Quesne

This study uses spatial transcriptomics to analyze gene expression in lung adenocarcinoma morphologies, revealing plasticity and gene expression trajectories linked to lethal growth patterns.

bioRxiv · Jun 11, 2024 · PreprintCancer Biology

Targeting Oncogenic Src Homology 2 Domain-Containing Phosphatase 2 (SHP2) by Inhibiting its Protein-Protein Interactions

S. Bobone, L. Pannone, B. Biondi, M. Solman, E. Flex, V. Canale, P. Calligari, C. De Faveri, T. Gandini, A. Quercioli, G. Torini, M. Venditti, A. Lauri, G. Fasano, J. Hoeksma, , L. Stella

This study develops peptide-based SHP2 inhibitors that target protein-protein interactions, showing higher affinity for pathogenic variants and efficacy in zebrafish embryos.

bioRxiv · Aug 28, 2020Biophysics